Showing results (1051-1060 of 8,791) with videos related to

Sort By:
Pageof 880
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Pediatric Blood & Cancer|September 17, 2013
Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in childrenMichael D Deel, Maiying Kong, Keith P Cross, et al.
Pediatric Blood & Cancer|September 17, 2013
Transcranial Doppler and brain MRI in children with sickle cell disease and high hemoglobin F levelsAkram Asbeutah, Renu Gupta, Osama Al-Saeid, et al.
Pediatric Blood & Cancer|September 17, 2013
How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?Ian Joseph Cohen, Johannes E Wolff
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Pediatric Blood & Cancer|September 17, 2013
Analysis of risk factors of cord blood transplantation for childrenGal Goldstein, Bella Bielorai, Jerry Stein, et al.
Pediatric Blood & Cancer|August 20, 2013
High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology GroupSadaf Altaf, Felicity Enders, Elysia Jeavons, et al.
Pediatric Blood & Cancer|August 20, 2013
Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcomaJeffrey R Scott, Deborah A Ward, Kristine R Crews, et al.
Pediatric Blood & Cancer|August 20, 2013
Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumorsAlexander J Neuwelt, Tam Nguyen, Y Jeffrey Wu, et al.
Pediatric Blood & Cancer|August 20, 2013
Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumorsDaniel A Morgenstern, Monia Marzouki, Ute Bartels, et al.
Pageof 880